Search results for "FDA update"
Warning on steroids; approval for soft-tissue sarcoma drug
This column reviews a warning on testosterone and other anabolic androgenic steroids and approval of a new drug to treat certain adults with soft-tissue sarcoma.
https://immattersacp.org/archives/2017/01/fda-update.htm
1 Jan 2017
New limitations on tolvaptan due to liver injury risk
The labeling for tolvaptan (Samsca) has been revised due to observation of increased risk of liver injury in recent trials, the FDA announced last week.
https://immattersacp.org/weekly/archives/2013/05/07/7.htm
7 May 2013
FDA proposes new category of OTC hearing aids
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/01/fda-proposes-new-category-of-otc-hearing-aids.htm
1 Jan 2022
Warning on IBS drug for patients without gallbladders
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/05/fda.htm
1 May 2017
ACP Hospitalist magazine relaunches with weekly online issues
ACP Hospitalist is a free and exclusive ACP member benefit covering the latest news in hospital medicine.
https://immattersacp.org/weekly/archives/2022/01/25/5.htm
25 Jan 2022
Tracheostomy tube shortage; fire risk with diabetes device
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/01/tracheostomy-tube-shortage-fire-risk-with-diabetes-device.htm
1 Jan 2023
OUD risk tests, gene therapies for sickle cell approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/02/oud-risk-tests-gene-therapies-for-sickle-cell-approved.htm
1 Feb 2024
Warnings on fluoroquinolones, antipsychotics, becaplermin
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2008/09/fda.htm
1 Sep 2008
Warnings about topical antiseptics, nuclear stress test agents
This regulatory update covers label and packaging changes to over-the-counter topical antiseptic products due to infection risk and approval of the first generic versions of rabeprazole sodium for gastroesophageal reflux disease.
https://immattersacp.org/archives/2014/02/fda.htm
1 Feb 2014
Warning on an antipsychotic; generic rosuvastatin approval
This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.
https://immattersacp.org/archives/2016/06/fda.htm
1 Jun 2016